Background Real-world data on patients' and physicians' values related to the use of oral
anticoagulant (OAC) therapy for stroke prevention in patients with nonvalvular atrial …

Atrial fibrillation (AF) is a chronic progressive disease characterized by exacerbations and
remissions. It remains the most common sustained arrhythmia seen in clinical practice, and …

Importance Patients with atrial fibrillation (AF) have impaired health-related quality of life
primarily owing to symptoms related to AF episodes; however, quality of life can be …

Nearly 30% of ischemic strokes have an unknown cause, which are referred to as
cryptogenic strokes (CS). Imaging studies suggest that a large proportion of these patients …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

Research has indicated that atrial fibrillation (AF) ablation failure is related to the presence
of atrial fibrosis. However it remains unclear whether this information can be successfully …

Statins, 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors, have been used for
decades for the prevention of coronary artery disease and stroke. They act primarily by …

Background Plasma trimethylamine-N-oxide (TMAO) is associated with cardiovascular
disease; however specific relationships with cardiac arrhythmias are unknown. We …

Background Several studies have investigated the effect of non–vitamin K antagonist oral
anticoagulants (NOAC s) in atrial fibrillation (AF) patients with cancer, but the results remain …

Atrial fibrillation is a highly prevalent cardiac arrhythmia and the most important cause of
embolic stroke. Although genetic studies have identified an increasing assembly of AF …